521 related articles for article (PubMed ID: 23181561)
1. A common copy-number breakpoint of ERBB2 amplification in breast cancer colocalizes with a complex block of segmental duplications.
Marotta M; Chen X; Inoshita A; Stephens R; Budd GT; Crowe JP; Lyons J; Kondratova A; Tubbs R; Tanaka H
Breast Cancer Res; 2012 Nov; 14(6):R150. PubMed ID: 23181561
[TBL] [Abstract][Full Text] [Related]
2. The fragility of a structurally diverse duplication block triggers recurrent genomic amplification.
Suzuki R; Murata MM; Manguso N; Watanabe T; Mouakkad-Montoya L; Igari F; Rahman MM; Qu Y; Cui X; Giuliano AE; Takeda S; Tanaka H
Nucleic Acids Res; 2021 Jan; 49(1):244-256. PubMed ID: 33290559
[TBL] [Abstract][Full Text] [Related]
3. Alu-mediated diverse and complex pathogenic copy-number variants within human chromosome 17 at p13.3.
Gu S; Yuan B; Campbell IM; Beck CR; Carvalho CM; Nagamani SC; Erez A; Patel A; Bacino CA; Shaw CA; Stankiewicz P; Cheung SW; Bi W; Lupski JR
Hum Mol Genet; 2015 Jul; 24(14):4061-77. PubMed ID: 25908615
[TBL] [Abstract][Full Text] [Related]
4. Large inverted duplications in the human genome form via a fold-back mechanism.
Hermetz KE; Newman S; Conneely KN; Martin CL; Ballif BC; Shaffer LG; Cody JD; Rudd MK
PLoS Genet; 2014 Jan; 10(1):e1004139. PubMed ID: 24497845
[TBL] [Abstract][Full Text] [Related]
5. Palindromic amplification of the ERBB2 oncogene in primary HER2-positive breast tumors.
Marotta M; Onodera T; Johnson J; Budd GT; Watanabe T; Cui X; Giuliano AE; Niida A; Tanaka H
Sci Rep; 2017 Feb; 7():41921. PubMed ID: 28211519
[TBL] [Abstract][Full Text] [Related]
6. Resolving the breakpoints of the 17q21.31 microdeletion syndrome with next-generation sequencing.
Itsara A; Vissers LE; Steinberg KM; Meyer KJ; Zody MC; Koolen DA; de Ligt J; Cuppen E; Baker C; Lee C; Graves TA; Wilson RK; Jenkins RB; Veltman JA; Eichler EE
Am J Hum Genet; 2012 Apr; 90(4):599-613. PubMed ID: 22482802
[TBL] [Abstract][Full Text] [Related]
7. Gene copy mapping of the ERBB2/TOP2A region in breast cancer.
Jacobson KK; Morrison LE; Henderson BT; Blondin BA; Wilber KA; Legator MS; O'Hare A; Van Stedum SC; Proffitt JH; Seelig SA; Coon JS
Genes Chromosomes Cancer; 2004 May; 40(1):19-31. PubMed ID: 15034864
[TBL] [Abstract][Full Text] [Related]
8. High-resolution genomic and expression analyses of copy number alterations in HER2-amplified breast cancer.
Staaf J; Jönsson G; Ringnér M; Vallon-Christersson J; Grabau D; Arason A; Gunnarsson H; Agnarsson BA; Malmström PO; Johannsson OT; Loman N; Barkardottir RB; Borg A
Breast Cancer Res; 2010; 12(3):R25. PubMed ID: 20459607
[TBL] [Abstract][Full Text] [Related]
9. New amplified and highly expressed genes discovered in the ERBB2 amplicon in breast cancer by cDNA microarrays.
Kauraniemi P; Bärlund M; Monni O; Kallioniemi A
Cancer Res; 2001 Nov; 61(22):8235-40. PubMed ID: 11719455
[TBL] [Abstract][Full Text] [Related]
10. Landscape of somatic allelic imbalances and copy number alterations in HER2-amplified breast cancer.
Staaf J; Jönsson G; Ringnér M; Baldetorp B; Borg A
Breast Cancer Res; 2011; 13(6):R129. PubMed ID: 22169037
[TBL] [Abstract][Full Text] [Related]
11. Concomitant gastrin and ERBB2 gene amplifications at 17q12-q21 in the intestinal type of gastric cancer.
Vidgren V; Varis A; Kokkola A; Monni O; Puolakkainen P; Nordling S; Forozan F; Kallioniemi A; Vakkari ML; Kivilaakso E; Knuutila S
Genes Chromosomes Cancer; 1999 Jan; 24(1):24-9. PubMed ID: 9892105
[TBL] [Abstract][Full Text] [Related]
12. [DNA structural features on the borders of ERBB2 amplicons in breast cancer].
Matsenko NIu; Kovalenko SP
Mol Biol (Mosk); 2013; 47(5):818-27. PubMed ID: 25509354
[TBL] [Abstract][Full Text] [Related]
13. Segmental duplication as one of the driving forces underlying the diversity of the human immunoglobulin heavy chain variable gene region.
Pramanik S; Cui X; Wang HY; Chimge NO; Hu G; Shen L; Gao R; Li H
BMC Genomics; 2011 Jan; 12():78. PubMed ID: 21272357
[TBL] [Abstract][Full Text] [Related]
14. Genomic Copy Number Analysis of HER2-Equivocal Breast Cancers.
Geiersbach KB; Willmore-Payne C; Pasi AV; Paxton CN; Werner TL; Xu X; Wittwer CT; Gulbahce HE; Downs-Kelly E
Am J Clin Pathol; 2016 Oct; 146(4):439-47. PubMed ID: 27614666
[TBL] [Abstract][Full Text] [Related]
15. Analysis of segmental duplications, mouse genome synteny and recurrent cancer-associated amplicons in human chromosome 6p21-p12.
Martin JW; Yoshimoto M; Ludkovski O; Thorner PS; Zielenska M; Squire JA; Nuin PA
Cytogenet Genome Res; 2010 Jun; 128(4):199-213. PubMed ID: 20453501
[TBL] [Abstract][Full Text] [Related]
16. Copy number gain at Xp22.31 includes complex duplication rearrangements and recurrent triplications.
Liu P; Erez A; Nagamani SC; Bi W; Carvalho CM; Simmons AD; Wiszniewska J; Fang P; Eng PA; Cooper ML; Sutton VR; Roeder ER; Bodensteiner JB; Delgado MR; Prakash SK; Belmont JW; Stankiewicz P; Berg JS; Shinawi M; Patel A; Cheung SW; Lupski JR
Hum Mol Genet; 2011 May; 20(10):1975-88. PubMed ID: 21355048
[TBL] [Abstract][Full Text] [Related]
17. Heterogeneous duplications in patients with Pelizaeus-Merzbacher disease suggest a mechanism of coupled homologous and nonhomologous recombination.
Woodward KJ; Cundall M; Sperle K; Sistermans EA; Ross M; Howell G; Gribble SM; Burford DC; Carter NP; Hobson DL; Garbern JY; Kamholz J; Heng H; Hodes ME; Malcolm S; Hobson GM
Am J Hum Genet; 2005 Dec; 77(6):966-87. PubMed ID: 16380909
[TBL] [Abstract][Full Text] [Related]
18. Increased copy number at 17q22-q24 by CGH in breast cancer is due to high-level amplification of two separate regions.
Bärlund M; Tirkkonen M; Forozan F; Tanner MM; Kallioniemi O; Kallioniemi A
Genes Chromosomes Cancer; 1997 Dec; 20(4):372-6. PubMed ID: 9408753
[TBL] [Abstract][Full Text] [Related]
19. Clinical array-based karyotyping of breast cancer with equivocal HER2 status resolves gene copy number and reveals chromosome 17 complexity.
Gunn S; Yeh IT; Lytvak I; Tirtorahardjo B; Dzidic N; Zadeh S; Kim J; McCaskill C; Lim L; Gorre M; Mohammed M
BMC Cancer; 2010 Jul; 10():396. PubMed ID: 20667129
[TBL] [Abstract][Full Text] [Related]
20. HapMap-based study of the 17q21 ERBB2 amplicon in susceptibility to breast cancer.
Benusiglio PR; Pharoah PD; Smith PL; Lesueur F; Conroy D; Luben RN; Dew G; Jordan C; Dunning A; Easton DF; Ponder BA
Br J Cancer; 2006 Dec; 95(12):1689-95. PubMed ID: 17117180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
